Masimo Taps Katie Szyman

Masimo Taps Katie Szyman as Permanent CEO
Masimo appointed Katie Szyman as its next chief executive officer and named current interim CEO Michelle Brennan as the new chair of the board. The medical technology company on Tuesday said that the executive changes will be effective Feb.
Masimo picks Katie Szyman as CEO
Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her appointment “fits like a glove,” BTIG analyst Marie Thibault wrote.
Masimo taps Becton Dickinson executive Katie Szyman as CEO
(This Jan. 21 story has been corrected to fix the share price gain to 57% from 45% in paragraph 6) (Reuters) - Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday,
Masimo names former Edwards Critical Care leader Katie Szyman as next CEO
Masimo (Nasdaq: MASI) + Masimo Corporation $172.4 1.44% Open 173.198 Day High 175.067 52 Week High 147.89 52 Week Low 75.22 announced today that it appointed Katie Szyman as its new CEO, effective Feb. 12, 2025.
Masimo names new CEO, new board chair and vice chair. And confirms a fresh direction.
Telehealth and Telecare News since 2005
Masimo names med-tech vet Katie Szyman CEO
Szyman, an industry leader with deep med-tech roots, to guide the company as it seeks to rebuild its reputation and revenues following a gritty two-year battle for control. Current CEO Michelle Brennan will serve as chairman of the Masimo board.
Masimo Appoints Katie Szyman as Permanent CEO
Masimo Corp. today announced Katie Szyman as its new chief executive, effective Feb. 12. Szyman is currently worldwide president of BD Advanced Patient Monitoring, the former Critical Care unit of Edwards Lifesciences Corp. that was acquired by Becton, Dickinson and Co. last year for $4.2 billion.
Masimo names Katie Szyman CEO
Masimo (MASI) announced that Katie Szyman has been appointed the next Chief Executive Officer of the Company. Interim CEO Michelle Brennan has
FierceBiotech17h
Masimo lands new CEO from BD's patient monitoring division
After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...
Cautious Optimism Amid Leadership Change and Strategic Uncertainty at Masimo
Needham analyst Michael Matson has maintained their neutral stance on MASI stock, giving a Hold rating on January 17.Invest with Confidence: ...
Business Wire2d
Masimo Announces Leadership Transition
Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointe ...